Zogenix Inc. is a pharmaceutical company engaged in the commercializing and developing products for the treatment of central nervous system disorders and pain.


Updates from The Motley Fool

Latest updates on Zogenix from Fool.com.  The Fool has written over 100 articles on Zogenix.
Why Zogenix Inc. Is Soaring Today

Traders cheer after the company reports positive clinical results. Here's what investors need to ...



Stock Performance

View Interactive ZGNX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Zogenix.
Current Price: $42.55
Prev Close: $43.61
Open: $43.40
Bid: $42.57
Ask: $44.22
Day's Range: $42.51 - $44.40
52wk Range: $33.42 - $62.75
Volume: 553,209
Avg Vol 538,808
Market Cap: $1B
P/E (ttm): -11.04
EPS (ttm): -$3.95
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Stephen Farr, Ph.D., CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Zogenix.

Zogenix Inc. is a pharmaceutical company engaged in the commercializing and developing products for the treatment of central nervous system disorders and pain.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers